(Q48216066)

9 February 2018

title

Active and remitted schizophrenia: psychopathological and regional cerebral blood flow findings. (English)

1 reference

9 February 2018

0 references

0 references

Erkwoh R

1

1 reference

9 February 2018

Sabri O

2

1 reference

9 February 2018

Willmes K

3

1 reference

9 February 2018

Steinmeyer EM

4

1 reference

9 February 2018

Büll U

5

1 reference

9 February 2018

Sass H

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

9 February 2018

published in

Psychiatry Research

1 reference

9 February 2018

volume

90

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

17-30

1 reference

9 February 2018

Negative symptoms in schizophrenia. Definition and reliability

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Frontal lobes, basal ganglia, temporal lobes--three sites for schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Schizophrenia--a brain disease? A critical review of structural and functional cerebral abnormality in the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Increased temporal lobe glucose use in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Psychopathological and SPECT findings in never-treated schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Abnormal distribution of cerebral activity in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Single photon emission computed tomography (SPECT) measures of brain function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

A relationship between metabolism in frontal lobes and cerebellum in normal subjects studied with PET

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Regional cerebral blood flow in schizophrenic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Positron emission tomographic measurements of pulvinar activity during an attention task.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Cerebellum and schizophrenia: a selective review.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Increased blood flow in Broca's area during auditory hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

The attention system of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Localization of cognitive operations in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Positron emission tomography and subcortical glucose metabolism in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Atrophy of the cerebellar vermis: relevance to the symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Structural and functional correlates of subsyndromes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

What does rCBF-SPECT offer in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Limbic System Abnormalities Identified in Schizophrenia Using Positron Emission Tomography With Fluorodeoxyglucose and Neocortical Alterations With Deficit Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Sight and insight: regional cerebral metabolic activity in schizophrenia visualised by positron emission tomography, and competing neurodevelopmental perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Regional cerebral blood flow in schizophrenia: repeated studies during a psychotic episode.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Cerebellar pathology in schizophrenia: a controlled postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2899%2900005-0

7 January 2021

10.1016/S0925-4927(99)00005-0

Identifiers

DOI

1 reference

9 February 2018

release_fqldv3yjmzbc5bdubtwuewqqhu

Fatcat ID

0 references

PubMed ID

10320208

1 reference

9 February 2018